Zacks Small Cap Research on MSN35m
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment Measures
AEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
Galecto Reports Third Quarter 2024 Financial Results
Third Quarter 2024 Financial Results Cash, cash equivalents, and investments as of September 30, 2024, were approximately $19.7 million. The Company anticipates that its cash, cash equivalents and ...